Please assess the completion status of the following clinical trial:

Trial Title: Follow-up Study to Evaluate Long-term Safety and Tolerability of Immunization With AD03 Applied During AFF005A

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Written informed consent signed and dated by the patient and the caregiver.~* Patients having participated in AFFiRiS 005A and received ≥1 vaccination with AFFITOPE AD03~* Availability of a partner/caregiver knowing the patient and being able to accompany the patient to the visits and being available for the telephone phone calls~Exclusion Criteria:~* Patients having received no vaccination with AFFITOPE AD03~* History of questionable compliance to visit schedule; patients not expected to complete the clinical trial

- Gender: ALL
- Minimum Age: 50 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- AFFITOPE AD03 with adjuvant (Type: None): None
- AFFITOPE AD03 without adjuvant (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).